Fired analyst ordered to pay ex-firm $10.7M

Finra arbitrators have ordered a securities analyst who claims he was wrongfully fired by Rodman & Renshaw LLC in 2006 for attempting to lower a stock rating to pay the broker-dealer $10.7 million in damages.
SEP 13, 2010
Finra arbitrators have ordered a securities analyst who claims he was wrongfully fired by Rodman & Renshaw LLC in 2006 for attempting to lower a stock rating to pay the broker-dealer $10.7 million in damages. Former Rodman biotech analyst Matthew N. Murray told the Senate Finance Committee that in March 2006 he was terminated after he tried to downgrade the stock of a company that was an investment banking client of the firm, according to a report in The New York Times. Rodman & Renshaw responded by suing Mr. Murray, alleging that he had defamed the firm and interfered with its business; the claim then went into arbitration. The Securities and Exchange Commission launched an investigation into Rodman in 2006 and later recommended no action against the firm. David Katz, Mr. Murray's attorney, said the three Finra arbitrators “rubber-stamped what Rodman had asked for.” Mr. Katz said he plans to appeal the decision. Edward Rubin, chief executive of Rodman & Renshaw Capital Group Inc., the broker-dealer's parent company, did not return a phone call seeking comment. Conflicts at securities firms between research analysts who rate securities and investment bankers are not uncommon on Wall Street. Following the crash in technology and telecom stocks, major financial institutions in 2002 entered into a global settlement with the SEC, NASD (now the Financial Industry Regulatory Authority Inc.) and the New York Stock Exchange that sanctioned brokerage firms for punishing analysts who publish negative reports about companies they follow. According to the Times report, Mr. Murray claimed that Rodman fired him after he tried to downgrade shares of a biopharmaceutical company whose stock price had exceeded Mr. Murray's target price. Rodman & Renshaw never published Mr. Murray's report, the Times reported. Rodman & Renshaw is a publicly traded boutique investment bank that focuses on start-up companies. The chairman of Rodman & Renshaw is Wesley K. Clark, a retired U.S. Army general who briefly sought the Democratic presidential nomination in 2004. Mr. Murray, who worked for Rodman in 2005 and 2006, no longer works for a brokerage firm, according to his record with Finra's Broker-Check system. As part of the litigation, he had asked for damages totaling $4 million; the three arbitrators denied his claim, according to the award published Aug. 26. As is typical in Finra arbitration claims, the panelists gave no explanation for the award. Mr. Katz said the $10.7 million award was the amount Rodman & Renshaw claimed it lost in delaying a private placement due to the negative publicity from the dispute. The arbitration process was lengthy, beginning in August 2007 and ending this March — totaling 61 sessions. Rodman & Renshaw had sought $15 million in punitive damages, but was denied, according to the award. E-mail Bruce Kelly at [email protected].

Latest News

Retirement plan defaults leave key participant decisions unresolved
Retirement plan defaults leave key participant decisions unresolved

New Allspring research finds 401(k) participants want guidance on income and rollovers, not just portfolio automation.

Global equity release market set to triple, with US leading growth
Global equity release market set to triple, with US leading growth

Aging homeowners hold record housing wealth - but most advisors still aren't bringing it into retirement plans

Retiree alleges advisor withheld $600K through real estate LLC web
Retiree alleges advisor withheld $600K through real estate LLC web

$1.7M invested from an inheritance. Then the phone went dead.

SEC accuses Linqto chiefs of 'Wizard of Oz' investor deception
SEC accuses Linqto chiefs of 'Wizard of Oz' investor deception

The pre-IPO platform sold $430M in units while allegedly rigging prices behind the scenes.

GLP-1 users are trading retirement savings for their prescriptions
GLP-1 users are trading retirement savings for their prescriptions

A Nationwide survey finds 47% of GLP-1 users have never discussed the drugs’ financial impact with an advisor, even as many dip into savings.

SPONSORED Built on insurance experience to deliver on long-term promises

Knighthead Life entered the market with a competitive MYGA. A strong launch earned advisor confidence and paved the way for FIAs.

SPONSORED In the Age of AI, Trust Becomes the Advisor's Greatest Asset

As AI makes financial information more accessible than ever, Lana Hock explains why human judgment, trust, and empathy remain the qualities clients value most in a financial advisor